dc.contributor.author |
Shete, P. B. |
|
dc.contributor.author |
Nalugwa, T. |
|
dc.contributor.author |
Farr, K. |
|
dc.contributor.author |
Ojok, C. |
|
dc.contributor.author |
Nantale, M. |
|
dc.contributor.author |
Howlett, P. |
|
dc.contributor.author |
Haguma, R. |
|
dc.contributor.author |
Ochom, E. |
|
dc.contributor.author |
Mugabe, F. |
|
dc.contributor.author |
Joloba, M. |
|
dc.contributor.author |
Chaisson, L. H. |
|
dc.contributor.author |
Dowdy, D. W. |
|
dc.contributor.author |
Moore, D. |
|
dc.contributor.author |
Davis, J. L. |
|
dc.contributor.author |
Katamba, A. |
|
dc.contributor.author |
Cattamanchi, A. |
|
dc.date.accessioned |
2021-01-01T21:58:16Z |
|
dc.date.available |
2021-01-01T21:58:16Z |
|
dc.date.issued |
2017 |
|
dc.identifier.issn |
1027-3719 |
|
dc.identifier.uri |
http://combine.alvar.ug/handle/1/48237 |
|
dc.description.abstract |
OBJECTIVE: To assess the feasibility of a streamlined strategy for improving tuberculosis (TB) diagnostic evaluation and treatment initiation among patients with presumed TB. DESIGN: Single-arm interventional pilot study at five primary care health centers of a streamlined, SinglesaMPLE (SIMPLE) TB diagnostic evaluation strategy: 1) examination of two smear results from a single spot sputum specimen using light-emitting diode fluorescence microscopy, and 2) daily transportation of smear negative sputum samples to Xpert MTB/RIF testing sites. RESULTS: Of 1212 adults who underwent sputum testing for TB, 99.6% had two smears examined from the spot sputum specimen. Sputum was transported for Xpert testing within 1 clinic day for 83% (907/1091) of the smear-negative patients. Of 157 (13%) patients with bacteriologically positive TB, 116 (74%) were identified using sputum smear microscopy and 41 (26%) using Xpert testing of smear-negative samples. Anti-tuberculosis treatment was initiated in 142 (90%) patients with bacteriologically positive TB, with a median time to treatment of 1 day for smear-positive patients and 6 days for smear-negative, Xpert-positive patients. CONCLUSION: The SIMPLE TB strategy led to successful incorporation of Xpert testing and rapid treatment initiation in the majority of patients with bacteriologically confirmed TB in a resource-limited setting. |
|
dc.description.sponsorship |
Medical Research Council/Wellcome Trust/UK Department for International Development (London, UK) [MR/M017362/1] |
|
dc.description.sponsorship |
US National Institutes of Health (NIH |
|
dc.description.sponsorship |
Bethesda, MD, USA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HL130192] |
|
dc.description.sponsorship |
NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 5T32HL007185-35] |
|
dc.description.sponsorship |
NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007185, T32HL007185, T32HL007185, R01HL130192, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, R01HL130192, T32HL007185, T32HL007185, T32HL007185, R01HL130192, R01HL130192, T32HL007185, T32HL007185, T32HL007185, T32HL007185, T32HL007185, R01HL130192] Funding Source: NIH RePORTER |
|
dc.description.sponsorship |
Medical Research CouncilMedical Research Council UK (MRC) [MR/M017362/1] Funding Source: researchfish |
|
dc.language |
English |
|
dc.publisher |
INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D) |
|
dc.relation.ispartof |
International Journal of Tuberculosis and Lung Disease |
|
dc.subject |
Tuberculosis |
|
dc.subject |
Diagnosis |
|
dc.subject |
Implementation Research |
|
dc.subject |
Xpert |
|
dc.title |
Feasibility of a streamlined tuberculosis diagnosis and treatment initiation strategy |
|
dc.type |
Article |
|
dc.identifier.isi |
000406254900007 |
|
dc.identifier.doi |
10.5588/ijtld.16.0699 |
|
dc.identifier.pmid |
28633698 |
|
dc.publisher.city |
PARIS |
|
dc.publisher.address |
68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE |
|
dc.identifier.eissn |
1815-7920 |
|
dc.identifier.volume |
21 |
|
dc.identifier.issue |
7 |
|
dc.identifier.spage |
746 |
|
dc.identifier.epage |
752 |
|
dc.subject.wc |
Infectious Diseases |
|
dc.subject.wc |
Respiratory System |
|
dc.subject.sc |
Infectious Diseases |
|
dc.subject.sc |
Respiratory System |
|
dc.description.oa |
Green Published |
|
dc.description.oa |
Green Accepted |
|
dc.description.pages |
7 |
|
dc.subject.kwp |
Sputum Smear Microscopy |
|
dc.subject.kwp |
Patient |
|
dc.subject.kwp |
Services |
|
dc.subject.kwp |
Costs |
|
dc.description.affiliation |
Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA |
|
dc.description.affiliation |
Zuckerberg San Francisco Gen Hosp, San Francisco, CA 94143 USA |
|
dc.description.affiliation |
Univ Calif San Francisco, Curry Int TB Ctr, San Francisco, CA 94143 USA |
|
dc.description.affiliation |
Makerere Univ, Sch Med, Coll Hlth Sci, Kampala, Uganda |
|
dc.description.affiliation |
London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England |
|
dc.description.affiliation |
London Sch Hyg & Trop Med, TB Ctr, London, England |
|
dc.description.affiliation |
Uganda Natl TB & Leprosy Control Programme, Kampala, Uganda |
|
dc.description.affiliation |
Makerere Univ, Sch Biomed Sci, Coll Hlth Sci, Kampala, Uganda |
|
dc.description.affiliation |
Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA |
|
dc.description.affiliation |
Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA |
|
dc.description.affiliation |
Yale Sch Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT USA |
|
dc.description.email |
priya.shete@ucsf.edu |
|
dc.description.corr |
Shete, PB (corresponding author), Zuckerberg San Francisco Gen Hosp, Div Pulm & Crit Care Med, 1001 Potrero Ave,5K1, San Francisco, CA 94110 USA. |
|
dc.description.orcid |
Davis, J. Lucian/0000-0002-8629-9992 |
|
dc.description.orcid |
Farr, Katherine/0000-0002-1818-1730 |
|
dc.description.orcid |
EMMANUEL, OCHOM/0000-0003-0999-3275 |
|